To test this, we performed an adoptive cell transfer of activated OT-1 cells (TCR transgenic CD8+ T cells specific for OVA) immediately prior to FUS+MBs BTB/BBB opening in B16F1cOVA tumors, 6 days after tumor implantation. Here, CD8A is linked to neoplasm.